XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.3
LEASES
9 Months Ended
Sep. 27, 2025
Leases  
LEASES

11. LEASES

 

The Company enters into operating leases primarily for: real estate, including for manufacturing, engineering, research, administration and sales facilities, and information technology (“IT”) equipment. At September 27, 2025 and December 28, 2024, the Company did not have any finance leases. Approximately all of its future lease commitments, and related lease liability, relate to the Company’s real estate leases. Some of the Company’s leases include options to extend or terminate the lease.

 

The components of lease expense were as follows:

 

   Three Months
Ended
   Three Months
Ended
   Nine Months
Ended
   Nine Months
Ended
 
   September 27, 2025   September 28, 2024   September 27, 2025   September 28, 2024 
Operating lease cost  $226,461   $218,348   $668,858   $651,718 

 

At September 27, 2025, the Company’s future lease payments under non-cancellable leases were as follows:

 

      
2025 (excluding the nine months ended September 27, 2025)  $225,099 
2026   897,570 
2027   834,215 
2028   242,573 
2029    
Total future lease payments   2,199,457 
Less effects of discounting   (193,534)
Total  $2,005,923 

 

The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheet at September 27, 2025 were as follows:

 

   September 27, 2025 
Operating lease liabilities–current  $775,814 
Operating lease liabilities–noncurrent   1,230,109 
Total lease liabilities  $2,005,923 

 

Supplemental cash flow information related to leases was as follows:

 

   Nine Months
Ended
   Nine Months
Ended
 
   September 27, 2025   September 28, 2024 
Cash paid for amounts included in the measurement of operating lease liabilities  $668,636   $649,276 

 

Other information related to leases was as follows:

 

   September 27, 2025   September 28, 2024 
Weighted Average Discount Rate–Operating Leases   6.52%   6.80%
Weighted Average Remaining Lease Term–Operating Leases (in years)   2.48    3.38